Carrelizumab (PD-1) Combined With Chemotherapy in Neoadjuvant Treatment of Locally Advanced Gastric Cancer
Clinical trial NCT05545436 · UNKNOWN
Trial details
- NCT number
- NCT05545436
- Sponsor
- Third Affiliated Hospital, Sun Yat-Sen University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-20
- Primary completion
- 2022-12-01
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.